About Tokyo Women's Medical University Medical Center East
東京女子医科大学東医療センター は、東京都荒川区西尾久で2021年12月31日まで診療を行っていた大学病院である。略称は、TWMU-MCEであった。現在は移転し東京女子医科大学附属足立医療センターとなる。 西日暮里に日暮里クリニックを併設していたが、2017年3月末を以て閉鎖された。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Tokyo Women's Medical University Medical Center East
During the past decade, Tokyo Women's Medical University Medical Center East conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on
average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Tokyo Women's Medical University Medical Center East" #1 sponsor was "Pfizer" with 3 trials, followed by "Biogen" with 2 trials
sponsored, "Shire" with 2 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored and "Japanese CT Colonography Society"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Tokyo Women's Medical University Medical Center East"
#1 collaborator was "Korean Gynecologic Oncology Group" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Tokyo Women's Medical University Medical Center East
According to Clinical.Site data, the most researched conditions in "Tokyo Women's Medical University Medical Center East" are
"Nervous System Diseases" (2 trials), "Carcinoma, Renal Cell" (1 trials), "Colonic Neoplasms" (1 trials), "Colonic Polyps" (1 trials) and "Cystitis, Interstitial" (1 trials). Many other conditions were trialed in "Tokyo Women's Medical University Medical Center East" in a lesser frequency.
Clinical Trials Intervention Types at Tokyo Women's Medical University Medical Center East
Most popular intervention types in "Tokyo Women's Medical University Medical Center East" are "Drug" (8 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "SHP615" (2 trials), "AG-013736" (1 trials), "CP-690,550" (1 trials) and "CT colonography and optical colonoscopy" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Tokyo Women's Medical University Medical Center East
The vast majority of trials in "Tokyo Women's Medical University Medical Center East" are
9 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Tokyo Women's Medical University Medical Center East
Currently, there are NaN active trials in "Tokyo Women's Medical University Medical Center East".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Tokyo Women's Medical University Medical Center East,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Tokyo Women's Medical University Medical Center East, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".